Back to news

STAAR Surgical Names Andrew Pilon as Vice President of Business Development

Business Wire•08/10/2026•15:14 ET
5

Key Highlights

  • ➤Andrew Pilon appointed STAAR Surgical vice president of business development
  • ➤Pilon joins from Johnson & Johnson Vision after nearly six years
  • ➤Pilon will pursue strategic partnerships, acquisitions, licensing, and portfolio expansion
  • ➤STAAR has sold more than 4 million ICLs across over 85 countries

Expert Statements

Warren Foust, President and Chief Executive Officer of STAAR Surgical

“Andrew brings a unique combination of clinical expertise, extensive ophthalmology experience, and a strong track record in strategic growth”

Warren Foust, President and Chief Executive Officer of STAAR Surgical

“Throughout his career, Andrew has demonstrated a talent for maximizing the value of existing technology while strengthening businesses through strategic licensing, partnerships, and structured investments. As we continue to grow EVO ICL, expand into new markets, and evolve our multi-product platform, I am confident that Andrew will help us identify and unlock new opportunities that accelerate innovation and broaden the range of products we can offer to patients and physicians.”

Andrew Pilon, Vice President of Business Development at STAAR Surgical

“I am thrilled to join the STAAR team during such an exciting time and look forward to helping the Company build on its leadership position in lens-based refractive surgery”

Andrew Pilon, Vice President of Business Development at STAAR Surgical

“Together, we will further strengthen STAAR’s strategic partnerships and alliances, identify promising new technologies, and pursue initiatives that broaden the Company’s capabilities, including with respect to additional uses of its proprietary Collamer material technology. The opportunities ahead are significant, and we are well positioned to expand our portfolio and pursue new avenues for innovation and growth.”

STAAR Surgical Names Andrew Pilon as Vice President of Business Development

Accomplished Ophthalmic Industry Executive and Clinician to Help Advance STAAR’s Strategic Partnerships, Innovation Opportunities, and Multi-Product Platform Strategy

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in